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Abstract. Fractional exhaled nitric oxide (FENO) is considered an indicator in the diagnostics and management of
asthma. In this study we present a laser-based sensor for measuring FENO. It consists of a quantum cascade laser
(QCL) combined with a multi-pass cell and wavelength modulation spectroscopy for the detection of NO at the sub-
part-per-billion by volume (ppbv, 1∶10−9) level. The characteristics and diagnostic performance of the sensor were
assessed. A detection limit of 0.5 ppbv was demonstrated with a relatively simple design. The QCL-based sensor
was compared with two market sensors, a chemiluminescent analyzer (NOA 280, Sievers) and a portable hand-
held electrochemical analyzer (MINO®, Aerocrine AB, Sweden). FENO from 20 children diagnosed with asthma
and treated with inhaled corticosteroids were measured. Data were found to be clinically acceptable within
1.1 ppbv between the QCL-based sensor and chemiluminescent sensor and within 1.7 ppbv when compared
to the electrochemical sensor. The QCL-based sensor was tested on healthy subjects at various expiratory flow
rates for both online and offline sampling procedures. The extended NO parameters, i.e. the alveolar region, airway
wall, diffusing capacity, and flux were calculated and showed a good agreement with the previously reported
values. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.JBO.17.1.017003]
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1 Introduction
Amethod for non-invasive monitoring of inflammation from the
respiratory system represents a challenge and so far, several
methods have been used, i.e. exhaled breath condensate,1 elec-
tronic nose,2,3 and nitric oxide detection.4,5 The discovery of
nitric oxide (NO) in the exhaled breath6 and its increased
value in asthmatics7 paved the way for technical developments.
Measurement of FENO (Fractional Exhaled NO) is known to be
flow dependent.8,9 The American Thoracic Society/European
Respiratory Society (ATS∕ERS) statement recommends mea-
suring FENO at a constant flow rate of 50 ml∕s (FENO0.05),
reflecting a trade-off between sensitivity and patient comfort.10
However, measurement of FENO at different flow rates, so-
called extended NO analysis (or known as flow-independent
parameters), can be used to calculate NO parameters providing
NO production from different compartments of the lung.11 The
NO parameters are the NO from the alveolar region (CANO) and
NO flux from the airways (J 0awNO), derived from a linear
model,12 and the airway wall content of NO (CawNO) and dif-
fusing capacity of NO over the airway wall (DawNO) that can be
calculated from a non-linear model.13 These NO parameters may
give new insight into respiratory diseases.
For medical applications, there is a great requirement for
a sensitive, accurate, compact, convenient and inexpensive
sensor. Several instruments are now available making use of
either chemiluminescence, electrochemical, or laser-based
technologies.14–18 Care has to be given to validate and calibrate
each device to avoid conflicting reports between studies. Che-
miluminescent detection of FENO is considered by many
researchers in the field as the “gold standard.” It provides accu-
racy and precision but is bulky and expensive, has high on-going
running costs, and also requires technical expertise in calibra-
tion, limiting their use in routine patient care. Electrochemical
sensors are convenient for development of portable hand-held
analysers. However, the reproducibility of FENO measurements
for absolute values is still subject to conflicting reports19–21 and
can have consequences of relying on a single estimate of the
level of FENO in driving clinical management. The advances
of quantum cascade laser (QCL) technologies have opened
up new opportunities for novel mid-infrared (mid-IR) gas sen-
sors. The QCL-based sensors are well suited for mid-infrared
spectroscopic trace gas sensing due to their narrow linewidth,
high power at room temperature, and continuous wave (CW)
operation at mid-IR wavelengths (3 to 24 μm).22,23 Several
approaches for the optical sensing of NO have been reported.
Sensors based on absorption spectroscopy using a multi-
pass cell24–26 or a high finesse cavity for cavity enhanced15,27,28
or cavity ring-down,29,30 photoacoustic spectroscopy,31 and
Faraday modulation spectroscopy32,33 have been successfully
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implemented to reach a detection sensitivity in the order of sin-
gle part per billion by volume (ppbv, 1∶10−9) and below.
In this paper, we report on the development and performance
evaluation of a laser-based NO sensor, utilizing a CW, thermo-
electrically cooled QCL as a light source. The sensor was vali-
dated for FENO measurements; linearity, selectivity, precision,
accuracy, and detection limit were determined. The QCL-based
sensor was tested on healthy adults and asthmatic children. Per-
formance comparisons were done with two other techniques,
namely chemiluminescence and electrochemical sensor.
2 Experimental
2.1 Gas Sensors
The QCL-based NO sensor uses wavelength modulation spec-
troscopy technique (WMS) and consists of a continuous-wave
distributed feedback quantum cascade laser (CW-DFB QCL)
operating in the wavelength region of 5.2 μm (1891to
1908 cm−1), a multi-pass cell, and a room temperature detec-
tor.24 The laser beam is sent through an astigmatic Herriott
absorption cell of 400 ml (AMAC-76, Aerodyne Research,
USA), offering a total optical path length of 76 m and which
consists of two concave mirrors where light is reflected multiple
times, enhancing the effective path length through the breath
sample. The absorbed amount of light at the output of the cell
is proportional to the NO concentration present in the cell. The
detection is performed by a photovoltaic detector (PV-6, Vigo
Systems) working at room-temperature, thus eliminating the
need for a highly sensitive liquid nitrogen-cooled IR detector,
simplifying daily use of the system and allowing long-term
automated operation. In order to improve sensitivity toward the
NO target limit of≤1 pbbv required for breath analysis, WMS is
implemented by modulating the injection current of the laser at a
frequency of 100 kHz. The absorption signal is transposed into a
frequency domain where noise sources are weaker, and absorp-
tion spectra is obtained by demodulating the detected signal at
the second harmonic (2f) using a lock-in amplifier (model
SR844, Stanford Research Systems) with the time constant set
to 100 μs. This approach allows a sensitivity of 0.5 ppbv within
1 s averaging. To reach a fast response of the system, a pressure
of 70 cmH2O is maintained in the multi-pass cell and a sample
flow rate of 900 ml∕min is generated. Therefore, the cell is
refreshed in less than 2 s, making the sensor suitable for online
monitoring of exhaled breath. A schematic arrangement of the
experimental setup is shown in Fig. 1. The QCL-based sensor
was calibrated with a reference mixture of 100 3 ppbv of NO
in N2 (prepared by VSL-National Dutch Metrology Institute)
before analysis of a breath sample. A N2 gas bottle was used
as a NO-free gas reference.
In this study, the performances of the QCL-sensor were
investigated. To do that, 11 gas mixtures were prepared from
our reference gas mixture (100 ppbv NO in N2) diluted in
pure N2 to cover the range 10 to 100 ppbv, and 14 gas mixtures
were made from a 20 ppm 2% bottle of NO for concentra-
tions up to 4 ppm. The different concentrations of NO were pro-
duced by using two mass flow controllers (Brooks Instrument,
max flow: 25 l∕h and 5 l∕h with an accuracy of 1%).
Contrary to the QCL sensor which directly measures the NO
concentration, the chemiluminescence system is based on the
reaction between NO and O3, which generates NO2 in the exited
form.34 When NO2 returns to a stable state, light is emitted. The
amount of light, which is proportional to the amount of NO, is
measured by a photomultiplier. Calibration of the Sievers NOA
280 was performed each day prior to use with the same mixture
of NO as with the QCL-based sensor, i.e. with N2 gas bottle and
100 3 ppbv of NO in N2. The sample flow into the Sievers is
200 ml∕min. The chemiluminescence analyzer is connected to
a computer with the NO analysis software, which provides a
graphical display of FENO concentration during the analysis
process.
Despite the chemiluminescence NO sensor being the gold
standard reference for NO measurements in breath, its use
for routine clinical practice is limited by its size and expense.
Portable hand-held, relatively inexpensive NO analysers based
on electrochemical analysis have been introduced on the market
a few years ago. The NIOX MINO (Aerocrine AB, Sweden)
Asthma Inflammation Monitor is one of the available sensors.
This sensor is ideally suited for use in primary care, where the
majority of asthma patients are managed. In this study, the accu-
racy of NIOX MINO measurements was assessed. The manu-
facturer stateed an accuracy of 5 ppbv of measured value
below 50 ppbv and 10% at or above 50 ppbv.
2.2 BreathCollection
The QCL-based sensor was used for FENO monitoring with
both online and offline breath-collection.
To perform online measurements, a commercially available
breath sampler (Loccioni, Italy) was used to monitor the pres-
sure of the exhaled breath within an acceptable range and to
measure the breath CO2 concentration level. The breath sampler
meets the American Thoracic Guidelines (ATS) for collecting
breath by providing a back pressure of 10 cmH2O, to ensure
soft palate closure and prevent nasal contamination, and
allowing the patient to maintain constant exhalation flow.
Fig. 1 Schematic of the QCL-sensor. The QCL beam at 5.2 μm is sent
into a 30 -cmmulti-pass cell, thus enhancing the absorption path length
to 76 m. Wavelength modulation is performed by modulating the laser
current at 100 kHz, and a 2f lock-in amplifier is used to demodulate the
signal. (Color online only.)
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The exhalation flow ranged from 15 to 250 ml∕s. The target
flow rate was maintained within 5%.
During the sampling, the collected breath entered the Loc-
cioni breath sampler. The CO2 concentration profile and
airway pressure were simultaneously displayed in graphical
forms on the sampler display. When the CO2 concentration
reached 3%, a part of the breath was sent to the NO sensor.
The 3% value has been chosen since it is the start of the
CO2 plateau for most of people. The FENO level in ppbv
was acquired and plotted in real-time on a computer screen.
In addition, the breath sampling pipe was heated to ≥38 °C
to prevent water condensation. A typical recorded signal at
flow 50 ml∕s is shown in Fig. 2. FENO level was sampled
after the estimated start of the CO2 plateau region. The end-
tidal of the CO2 exhalation trend determines the point where
the NO plateau is measured, i.e. 5 s before the end-tidal CO2
point. One breath sample was collected at each flow rate (15,
50, 100 and 250 ml∕s) from each patient.
Offline collections were also performed as samples can be
collected at a distant collection site from the NO sensor. A cus-
tom-built breath-collection device was used to collect single
breaths into bags with the subject exhaling at specific constant
flow rates.35 The breath-collection device was based on the
guidelines of the ATS for the sampling of exhaled NO; it is
very simple, inexpensive, and has been tested in previous stu-
dies. The exhaled breath line consists of a mouth-piece con-
nected to a discard bag (400 ml) and an NO-impermeable
aluminum-foil air bag of 500 ml capacity (Mylar balloon,
ABC ballonnen, Zeist, The Netherlands).36 To maintain a con-
stant exhalation flow, the mouth pressure was monitored by
the patient during the sampling process. Breath was collected
at various constant flow rates from each subject by changing
the resistance of the breath line to maintain a mouth pressure of
10 cmH2O.
To assess the agreement of the two sampling procedures, off-
line FENO measurements in comparison to online measure-
ments, 23 healthy individuals performed online and offline
single breath maneuvers at a flow of 50 ml∕s. To prevent
systematic errors, 11 persons did first online followed by offline
breath maneuvers, and 12 in the reverse order.
2.3 Extended NO Analysis
Different exhalation flow rates can be performed with both
online and offline exhaled breath measurements by changing
the resistance of the sampling line and keeping a back pressure
of 10 cmH2O during the exhalation. Measuring the NO plateau
for multiple flow rates allows an estimation of the NO extended
parameters, which may provide additional useful clinical infor-
mation. The simple two-compartment model12 describes
exhaled NO arising from two compartments: the airways and
the alveolar region. It is based on three flow-independent
exchange parameters, one describing the steady-state NO
alveolar concentration (CANO, ppbv), and two describing the
airway region (the airway NO diffusing capacity (DawNO,
pl · s−1 · ppbv−1) and the airway wall NO concentration
(CawNO, ppbv).
11 The potential of these parameters lies in
their ability to split exhaled NO into two important anatomic
subdivisions of the lungs and also to provide both structural
and metabolic information relevant to the NO pathways. To
determine the airway and alveolar contribution to exhaled
NO, multiple exhalation flow rates must be accomplished. Dif-
ferent approaches are described in the literature11 and recently
used in combination with a QCL-based sensor to determine
extended NO parameters in chronic obstructive pulmonary dis-
ease.37 We selected the method described by Högman et al.13,38
as it requires only three exhalation flows. This method is based
on a non-linear model with a quality control to notify erroneous
NO values. NO values from different flow rates are included into
a software program with a second order algorithm, which will
render values of CANO, CawNO and DawNO.
We measured FENO at different flow rates controlled by the
Loccioni sampler: a low exhalation flow (15 ml∕s), a medium
flow (100 ml∕s), and a high flow rate (250 ml∕s). To validate
the sampling system, the exhalation flow of 50 ml∕s is also
measured (FENO0.05) and compared to calculated value by the
model. A group of 20 subjects performed online single breath
maneuvers at four expiratory flows as mentioned previously.
After each maneuver, the subject was given a 1-minute pause
before performing the next exhalation at a different flow.
3 Results
3.1 QCL-Based Sensor Performance
Prior to the study on patients, the performance of our QCL-
sensor was evaluated. With the prepared NO concentrations,
the QCL-sensor was tested in terms of linearity, precision, accu-
racy, sensitivity, and selectivity. To minimize random error, the
Fig. 2 Recorded data during online sampling of a single exhalation at
50 ml∕s. During the exhalation process the mouth pressure is moni-
tored to keep a constant flow rate (a). The exhaled breath is sent to
the QCL-based sensor when the CO2 concentration reaches 3% (b).
The average of the last 5 seconds of the exhaled breath was used to
calculate the FENO value (c).
Table 1 Main characteristics of the QCL-sensor.
Sensitivity <1 ppbv in 1 s
Repeatability (Precision) 5%
Accuracy 99%–104%
Dynamic Range 1 ppbv–4 ppmv
Response Time Lag Time: 2 s
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concentrations were measured six times. One measurement con-
sists of flushing the absorption cell for 5 min with the gas and
by taking the last value displayed by our sensor. Table 1 sum-
marizes the main characteristics of the sensor. The linearity
response of the system, Fig. 3, is given by the coefficient of
determination (R2 ¼ 0.998). Precision of the sensor was evalu-
ated in conditions of their repeatability, and accuracy was
determined by comparing the mixtures and the measured con-
centration. The calculated accuracy was between 99 and 104%
and is limited by the accuracy of the mass flow controllers used
for the dilution. The precision of the system expressed as RSD
(relative standard deviation) was below 5%.
The best minimum detectable NO concentration achieved
with QCL-based sensor with a 1 s averaging time is 0.5 ppbv.
A better sensitivity can be reached by increasing the integration
time. An Allan variance analysis of the data, which presents the
variance of the data as a function of integration time of the sam-
pling, is shown in Fig. 4. It displays the reduction in noise level
as the integration time is increased.
As exhaled breath carries a number of compounds at high
concentration such as water and CO2, the selectivity of the sen-
sor is important. The emission spectrum of the QCL allows
accessing of the NO absorption line within the fundamental
vibration band without interference of water and CO2, as shown
in the HITRAN simulation.39 The response of the QCL sensor
to humid air and 5% CO2 has been experimentally investi-
gated and has provided good agreement with the HITRAN
calculations.
3.2 Offline/Online Comparison
The QCL-based sensor can perform FENOmeasurements online
or offline. If the advantages of online analysis are obvious, the
benefits of offline analysis are apparent when analyzing large
sample numbers, for example during clinical studies. To exam-
ine the diagnostic capability of our sampling procedure, online
and offline measurements in the same subjects are compared,
using the Bland-Altman method.40 The Bland-Altman plot,
Fig. 5, consists of the difference between a pair of measurements
(in this case offline–online) versus their average. On average,
the difference in NO concentration between the two sampling
methods (offline-online) was −0.1 ppbv and the limit of agree-
ments was 1.0 ppbv. By measuring the NO concentration in
bags within 24 h of collection, no significant differences or com-
bined effects of measurement technique or flow rate were noted.
The sample is reportedly stable for up to 24 h, but it was
observed that NO concentrations in bags decreased over time
up to 7% after 48 h (data not shown).
3.3 Validation of QCL-Based Sensor for Multiple
Flows Analysis
For each individual, the three independent parameters are cal-
culated. Figure 6 shows the data as medians with lower and
upper quartiles (25 to 75%). The level of agreement between
the measured and calculated FENO0.05 is determined by the
coefficient of determination R2 (average between calculated
and measured: −0.4 ppbv, SD ¼ 0.72, R2 ¼ 0.9997). Data
Fig. 3 Linearity of the QCL sensor. Measured NO concentrations versus
prepared dilutions from a standard calibration mixture of 100 3 ppbv
of NO in N2 are plotted (R2 ¼ 0.9998).
Fig. 4 Allan variance showing the QCL-based sensor detection limit.
The sensitivity is 0.5 ppbv of NO with an acquisition time of 1 second.
A minimum detection limit of 0.24 ppbv is reachedwith 26 s integration
time.
Fig. 5 Bland-Altman plot comparing 23 offline and online sampling
procedures. Solid line represents the mean difference between values
obtained using the two sampling methods (−0.1 ppbv). Dashed lines
represent the limits of agreement −2.1 ppbv and 1.9 ppbv; SD is stan-
dard deviation. The plot indicates the sampling procedures are in good
agreement.
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are also compared to previous results, and these results are in
agreement with values presented by Högman et al.41 Regardless
of the lack of agreement about what flow rates to use to calculate
extended NO parameters, those results demonstrate the validity
of our sampling procedure and confirm the efficiency of the
theoretical model to give values which are consistent.
3.4 Comparison of the QCL-Based Sensor with
Chemiluminescence and Electrochemical Sensors
FENO from 22 asthmatic children (age range: 6 to 16 years) was
measured with three sensors. They provided offline samples in
aluminum bags for the QCL-based sensor and the chemilumi-
nescence, respectively, at flow 50 ml∕s, followed by online
FENO sample measured by the NIOX MINO two minutes
later. Ambient NO varied between 1 and 4 ppbv over the study.
The bags were measured simultaneously with the QCL-based
and the chemiluminescent sensors on the same day as the
sampling. Measurements were achieved with a 1 s integration
time for both devices. The Bland-Altman plot, Fig. 7(a),
shows a high degree of agreement between the QCL-based sen-
sor and the chemiluminescence device with an average differ-
ence of −0.1 ppbv and a standard deviation of 1.1 ppbv.
The comparison between the QCL-based sensor and the
NIOX MINO, Fig. 7(b), shows an average value of 1.6 ppbv
with a SD of 1.7 ppbv.
4 Discussion
This study reports a QCL sensor, combining a multi-pass cell
and wavelength modulation spectroscopy, suitable for FENO
measurements. The achieved sensitivity of 0.5 ppbv within
1 s integration time, appropriate for FENO measurements, is
comparable with other on-going optical sensor developments
and does not represent the ultimate sensitivity. The fast response
time achieved (<2 s), despite the use of a multi-pass cell, allows
online analysis by providing enough time resolution to follow
NO variations during a single breath, as well as offline measure-
ments. Although presently used in a setup configuration, the
QCL sensor has a real potential to be developed and integrated
into a compact and convenient device configured for autono-
mous operation in clinical applications.
For the present work, the obtained results are directly com-
parable with those obtained by the chemiluminescent NIOX
sensor, the device currently considered as the gold standard for
measuring FENO. A Bland-Altman plot demonstrated good
agreement between both devices for a wide range of NO con-
centrations, making the system trustable on any asthmatic
patient regardless of the degree of airway inflammation. When
coupled with a commercial or home-made sampler, single or
multiple flow rates can be easily performed. The only require-
ment is to be able to monitor CO2, the flow rate, and mouth
pressure during the exhalation. The system offers a wide number
of configurations fitting to each study, including extended NO
analysis. The possibility of measuring multiple flow rates was
demonstrated in healthy subjects by successfully comparing cal-
culated extended NO parameters (from FENO0.015, FENO0.10,
FENO0.25) with previous papers.
41 In addition, the calcu-
lated FENO0.05 from the model is in agreement with the mea-
sured FENO0.05. By adapting the sampler device, any flow
Fig. 6 Calculated NO extended parameters characterizing the alveolar
region (CANO), airway wall (CawNO), diffusing capacity (DawNO), and
flux (JawNO) NO exchanges using the model proposed by. Ref. 13 Mini-
mum, median, maximum and, interquartile ranges (25%, 75%) are
displayed. The data from the QCL-based sensor are included in the
ranges suggested by Högmann and et al.41 for healthy subjects
(hatched boxes). (Color online only.)
Fig. 7 Bland-Altman plot comparing the QCL-based sensor with che-
miluminescence device (a) and with NIOX MINO (b), respectively.
(a) Solid line represents the mean difference between values obtained
using the QCL-based sensor and chemiluminescence (−0.1 ppbv).
Dashed lines represent the limits of agreement, −2.3 ppbv and
2.1 ppbv. The plot suggests the two sensors are in good agreement.
(b) Solid line represents the mean difference between values obtained
using the QCL-based sensor and NIOX MINO (1.6 ppbv). Dashed lines
represent the limits of agreement, −1.8 ppbv and 5 ppbv; SD is standard
deviation. The plot suggests the QCL-sensor and NIOX MINO are quite
similar and reveals one outlier.
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rate can be used with the QCL sensor. A recent study also
demonstrated the efficiency of a QCL-based sensor for multiple
flow rates analysis in diseases other than asthma, as in chronic
obstructive pulmonary disease.37
We also found a statistically significant difference (p-value ¼
0.0003) between FENO values measured by the QCL-sensor and
the NIOX MINO. Ekroos et al.42 reported on the exhaled NO
from a selected group of healthy non-smoker adults and
assessed their long-term variation. The variation of NO concen-
trations (95% confidence interval) was 1.1 1 ppb within the
interval of seven days. This is in agreement with the difference
in the methods we report here. When patients start treatment this
effect is much larger. Silkoff et al.43 showed that the reduction in
exhaled NO was around 40%. Therefore, we conclude that the
difference between the two methods is not medically relevant
for the measurement of FENO0.05.
The validity of the NIOXMINO has been subject of conflict-
ing papers. Some studies reported strong correlations and
excellent reproducibility of the absolute value of FENO mea-
surements obtained using the NIOX MINO.44,45 They support
the recommendation of performing only one measurement.
Other studies did not support that conclusion.20,46 Our data sug-
gests that even by performing one FENOmeasurement, the level
of agreement between the gold standard device, the QCL-sensor,
and the NIOX MINO is certainly clinically acceptable. How-
ever, the 5 ppbv sensitivity prevents its use in determining the
extended NO parameters.
In conclusion, this study shows that there is clinically accep-
table agreement between the three main technologies used for
the development of NO sensors. Whereas chemiluminescence
analysers tend to be expensive, large and poorly portable,
laser-based systems and electrochemical sensors demonstrate
interesting opportunities to make FENO measurements in the
primary care. Compared to the NIOX MINO and generally to
electrochemical sensors, QCL-based systems, using highly
selective optical spectroscopy principles, offer higher sensitiv-
ities and have already proven their advantages as a trustable
and accurate technique over time. They are also suitable for
multiple flow rates analysis as they can perform analysis at
any flow without modification of the sensor. Compact devices
based on laser spectroscopy are presently used in many fields of
life sciences, and it is a matter of time before they will be used in
any hospital for diagnosis, monitoring, and control of diseases
such as asthma at single or multiple flow rates.
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